Literature DB >> 18632833

Aortic valve calcification: basic science to clinical practice.

K Akat1, M Borggrefe, J J Kaden.   

Abstract

Calcific aortic valve stenosis is the result of regulated cell processes. The histological hallmarks are inflammation and a remodelling of the extracellular matrix leading to bone formation. In the last 15 years the view has changed from it being an unmodifiable degenerative disease to an active biological process regulated by highly conserved ubiquitous cellular pathways. Many mechanisms and risk factors are the same as in atherosclerosis. Thus, statins and angiotensin II antagonists seemed promising treatment options. However, clinical trials failed to support this. This review describes the current understanding of major molecular mechanisms and discusses their role in clinical practice and possible therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632833     DOI: 10.1136/hrt.2007.134783

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

Review 1.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

2.  NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium.

Authors:  Mark P White; Christina V Theodoris; Lei Liu; William J Collins; Kathleen W Blue; Joon Ho Lee; Xianzhong Meng; Robert C Robbins; Kathryn N Ivey; Deepak Srivastava
Journal:  J Mol Cell Cardiol       Date:  2015-04-12       Impact factor: 5.000

3.  Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.

Authors:  Jae-Joon Jung; Mahmoud Razavian; Azariyas A Challa; Lei Nie; Reza Golestani; Jiasheng Zhang; Yunpeng Ye; Kerry S Russell; Simon P Robinson; Donald D Heistad; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

4.  Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.

Authors:  Zhen-kun Yang; Chen Ying; Hong-yan Zhao; Yue-hua Fang; Ying Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

5.  RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

Authors:  Sandra Guauque-Olarte; Arnaud Droit; Joël Tremblay-Marchand; Nathalie Gaudreault; Dimitri Kalavrouziotis; Francois Dagenais; Jonathan G Seidman; Simon C Body; Philippe Pibarot; Patrick Mathieu; Yohan Bossé
Journal:  Physiol Genomics       Date:  2016-08-05       Impact factor: 3.107

6.  [Functional cardiac MRI for assessment of aortic valve disease].

Authors:  F Sagmeister; S Herrmann; C Ritter; W Machann; H Köstler; D Hahn; W Voelker; F Weidemann; M Beer
Journal:  Radiologe       Date:  2010-06       Impact factor: 0.635

7.  Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease.

Authors:  Ana M Porras; Jennifer A Westlund; Austin D Evans; Kristyn S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

8.  Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Authors:  Jacqueline D Peacock; Agata K Levay; Devin B Gillaspie; Ge Tao; Joy Lincoln
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

Review 9.  Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.

Authors:  Thomas E Claiborne; Marvin J Slepian; Syed Hossainy; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2012-11       Impact factor: 3.166

10.  Biventricular adaptation to volume overload in mice with aortic regurgitation.

Authors:  Christopher J Berry; Jordan D Miller; KellyAnn McGroary; Daniel R Thedens; Stephen G Young; Donald D Heistad; Robert M Weiss
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.